Screener
Charles River Laboratories CRL Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Other current liabilities | 222,792 | 222,158 |
| Total current liabilities | 1,134,746 | 1,120,315 |
| Long-term debt, net and finance leases | 2,619,985 | 2,136,360 |
| Operating lease right-of-use liabilities | 407,708 | 434,048 |
| Deferred tax liabilities | 78,668 | 95,203 |
| Other long-term liabilities | 402,511 | 138,302 |
| Total liabilities | 4,643,618 | 3,924,228 |
| Commitments and contingencies (Notes 2, 12, 14, and 16) |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's operating lease liabilities?
- Charles River Laboratories (CRL) reported operating lease liabilities of $407.71M in Q2 2026.
- How has Charles River Laboratories's operating lease liabilities changed year-over-year?
- Charles River Laboratories's operating lease liabilities decreased by 10.1% year-over-year, from $453.66M to $407.71M.
- What is the long-term trend for Charles River Laboratories's operating lease liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's operating lease liabilities has grown at a 22.8% compound annual growth rate (CAGR), from $155.6M to $434.05M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Charles River Laboratories's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude